HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R M Orr Selected Research

Therapeutics

10/2001GTI-2040. Lorus Therapeutics.
2/2000Molecular targets and cancer therapeutics: discovery, development & clinical validation--AACR-NCI-EORTC international conference.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R M Orr Research Topics

Disease

4Neoplasms (Cancer)
10/2001 - 02/2000
1Renal Cell Carcinoma (Grawitz Tumor)
10/2001
1Acquired Immunodeficiency Syndrome (AIDS)
06/2001
1Retinitis
06/2001
1Inflammation (Inflammations)
06/2000
1Carcinoma (Carcinomatosis)
02/2000
1Necrosis
02/2000

Drug/Important Bio-Agent (IBA)

1GTI2040IBA
10/2001
1Antisense OligonucleotidesIBA
10/2001
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2001
1Capecitabine (Xeloda)FDA Link
10/2001
1fomivirsen (Vitravene)FDA Link
06/2001
1Antiviral Agents (Antivirals)IBA
06/2000
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2000
1PhenanthrolinesIBA
02/2000
1casiopeina IIIBA
02/2000
1Antineoplastic Agents (Antineoplastics)IBA
02/2000
1CopperIBA
02/2000
1Cisplatin (Platino)FDA LinkGeneric
02/2000
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2000

Therapy/Procedure

2Therapeutics
10/2001 - 02/2000
1Intravitreal Injections
06/2001